Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.

Xue, Sheng; Guo, Hanxu; Wei, Shibo; Song, Yuan; Huang, Junfeng; Deng, Shuo; Li, Qingwen; Li, Wenyong

Xue, Sheng; Guo, Hanxu; Wei, Shibo; Song, Yuan; Huang, Junfeng; Deng, Shuo; Li, Qingwen; Li, Wenyong.

Afiliação

Xue S; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Guo H; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Wei S; School of Anesthesiology, Bengbu Medical College, Bengbu, China.
Song Y; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Huang J; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Deng S; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Li Q; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Li W; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Transl Androl Urol ; 11(9): 1304-1317, 2022 Sep.

Article em En | MEDLINE | ID: mdl-36217399

Palavras-chave

Clear cell renal cell carcinoma (ccRCC); mitotically-associated lncRNA (MANCR); prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Transl Androl Urol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google